1. The 28-Day Puncture Rule Explained
In pharmaceutical compounding, clinical research, and sterile product management, the 28-day rule is a recognised standard with two independent sources behind it: United States Pharmacopeia (USP) General Chapter <797> (Pharmaceutical Compounding: Sterile Preparations), which sets a 28-day beyond-use date for multiple-dose containers after they are first entered unless antimicrobial effectiveness testing establishes otherwise,1 and the U.S. Centers for Disease Control and Prevention, whose injection-safety guidance states it plainly:
“Once a multi-dose vial is opened (e.g., needle-punctured) the vial should be dated and discarded within 28 days unless the manufacturer states another date for that opened vial.” (CDC, Preventing Unsafe Injection Practices)2
Two details in that sentence matter and are routinely missed. First, the clock starts at the first puncture, not at purchase. Second, CDC is explicit that “the beyond-use-date should never exceed the manufacturer’s original expiration date”2, so 28 days is a ceiling, not an extension. If a vial has six days of labelled shelf life left when you open it, you have six days, not twenty-eight.
While unpunctured vials of bacteriostatic water are stored at a labelled 20°C to 25°C and carry a manufacturer expiration date,3 the moment a needle pierces the septum, the 28-day countdown begins. CDC’s companion guidance is equally practical: “As soon as you draw up the first dose, write the date and time on the label indicating when the vial was opened.”4
2. Why 28 Days? What Is Documented and What Is Rationale
A common question is: “If benzyl alcohol halts bacterial growth, why can’t an opened vial last indefinitely?” The honest answer separates the parts that are written into standards from the reasoning behind them.
1. The preservative is there for the doses, not for ever
USP’s antimicrobial effectiveness chapter, USP <51>, states the purpose directly: in sterile multiple-dose containers, preservatives are added “to inhibit the growth of microorganisms that may be introduced from repeatedly withdrawing individual doses.”5 USP <797> then ties the 28-day limit to that testing: the beyond-use date applies unless otherwise specified by antimicrobial effectiveness testing for the specific formulation.1 Benzyl alcohol is genuinely membrane-active. In a study of phenolic compounds and aromatic alcohols, every compound tested showed lethal properties and the ability to alter membranes, with efficacious concentrations varying widely and mechanism tracking lipophilicity.6 But a fixed 9 mg/mL reserve, the concentration declared on the label and specified in the USP-NF monograph,73 holds trace contamination in check. It is not a sterilisation step for a vial that keeps being entered.
2. Every entry is a new chance for contamination
The label itself calls for aseptic technique “for single or multiple entry and withdrawal from all containers.”3 Each entry can carry whatever is on the stopper surface, the needle or the syringe into the vial, which is why CDC’s multi-dose vial steps include a brand-new needle and syringe for every dose and disinfecting the stopper every time.4 A 28-day limit caps how long one bad entry can keep being drawn into later doses.
3. The stopper takes wear
The rubber stopper is designed to reseal after a needle passes through it, but each passage can cut or abrade it, and fragments cut from a stopper (coring) are one reason vials are inspected before use. We found no published figure for how many entries a given stopper tolerates, which is one reason the limit is expressed in days rather than in punctures.
How firm is this one? The mechanisms above are the accepted rationale for a fixed re-entry limit, but the 28-day figure itself is set by USP <797> and echoed by CDC as a conservative administrative limit. It is not a measured expiry curve for any one product, and we are not aware of data showing benzyl alcohol falling below a threshold on day 28.12 Where a manufacturer states a different date for an opened vial, CDC is explicit that the manufacturer’s date governs.2
3. What CDC’s Outbreak Record Shows About Opened Vials
Most pages on the 28-day rule stop at the number. We went back to what actually harms patients. CDC’s 2013 Grand Rounds report counted at least 49 outbreaks since 2001 caused by contamination of injectable products at the point of administration: 21 involved hepatitis B or C transmission and 28 were bacterial, mainly bloodstream infections. About 90% occurred in outpatient settings, and an estimated 150,000 patients were told to get tested for bloodborne infections during 2001 to 2012 after possible exposure to unsafe injections.8
We pulled the vial-handling events from CDC’s 2010 to 2014 outpatient table
CDC publishes a table of selected outbreaks and patient notifications in outpatient settings for 2010 to 2014.9 We extracted every event where the listed breach involved medication vials. The pattern is consistent: the harm came from how a vial was entered or shared, not from a vial simply getting old.
| Setting, year | Pathogen or outcome | Patients notified | Vial-related breach CDC listed |
|---|---|---|---|
| Oral surgery clinic, 2013 | Hepatitis C | 5,810 | Reuse of single-dose vials of propofol |
| Pain management clinic, 2010 | Hepatitis B and C | 2,293 | Syringe reuse contaminating medication vials used for more than one patient |
| Surgical center, 2014 | Breach prompted notification | 1,100 | Reuse of syringes to access medication vials used for more than one patient |
| Oncology clinic, 2011 | Bloodstream infections | 623 | Reuse of syringes to access medication containers used for more than one patient |
| Pain management clinic, 2011 | Hepatitis C | 466 | Suspected syringe reuse contaminating medication vials |
| Plastic surgery center, 2013 | Breach prompted notification | 415 | Reuse of syringes to access vials that may have been used for more than one patient |
| Rheumatology clinic, 2011 | Staphylococcus aureus skin and soft tissue infections | None listed | Undated, open multi-dose vials and single-dose vials kept in patient areas |
Source: CDC, Outbreaks and Patient Notifications in Outpatient Settings, Selected Examples, 2010 to 2014.9 CDC notes the list is not exhaustive, and a notification count is not a count of infections.
Three lessons carry over to anyone who draws from a multi-dose vial. First, CDC’s table flags a practice it calls “double dipping”: a syringe already used on a patient goes back into a vial, and later doses from that vial carry the contamination.9 Second, an undated vial is itself on CDC’s list of breaches, which is why writing the first-puncture date on the label is part of the rule and not a formality. Third, the preservative did not prevent these events. It is a backstop for trace contamination, not for a contaminated syringe.
CDC’s Project Firstline, writing about multi-dose vaccine vials, makes the syringe point in plain terms:
“Just using a new needle is not enough because if the syringe has been used, blood can get into the vial when you draw up the vaccine. Even if the syringe looks clean, you could risk the spread of viruses like hepatitis C or HIV.”
Joseph Perz spent his CDC career investigating outbreaks like these and trained as an engineer before entering public health. His reflection on that work explains why fixed limits like 28 days exist at all:
“Engineers design systems for reliability and apply safety margins to account for human error. It was deeply unsettling to recognize how much healthcare relied on assumptions and trust.”
Read the 28-day limit the same way: a safety margin that assumes technique will occasionally slip, and limits how long a slip can matter.
4. Proper Storage Conditions: What to Do & What to Avoid
| Vial State | Target Temperature | Recommended Location | Avoid |
|---|---|---|---|
| Unopened (Sealed) BAC Water | 20°C to 25°C (68°F to 77°F)3 | Climate-controlled cabinet away from direct sun and heat sources | Hot vehicles; freezing |
| Punctured BAC Water | 20°C to 25°C, as labelled | Clean preparation area, labelled with the first-puncture date | Freezing; use past 28 days or past the printed date, whichever comes first |
| Solution After Mixing With a Drug | Set by the drug’s own label, often 2°C to 8°C | Refrigerator shelf when the drug label calls for it (not the door, where temperature swings) | Storing it at all unless the drug’s manufacturer directs it3 |
The last row is the one most guides get wrong. The bacteriostatic water label says: “Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute.”3 The diluent’s 28 days does not transfer to whatever you mix it with. How long a mixed drug keeps is a property of that drug, which our bacteriostatic water storage guide shows with label examples.
Why You Should Not Freeze Bacteriostatic Water
The approved label gives one storage instruction, 20 to 25°C (68 to 77°F), and lists no freezing option,3 so a vial that has frozen is outside the conditions its expiration date was based on. There is a physical reason too: water expands as it freezes, and in a filled, sealed vial that pressure lands on the stopper and the container wall. Hospira’s 30 mL presentation is a semi-rigid polyolefin plastic vial, while its 20 mL fill comes in glass;3 Type I glass is classified for hydrolytic resistance, not for surviving a phase change under seal.10 Damage from freezing is not always visible, so treat a vial that has frozen as compromised. Freezing does not add time to either the expiration date or the 28-day limit.
5. Avoiding Waste: Choosing Between 10 mL and 3 mL Vials
The 28-day limit, not the expiration date, is what usually ends a vial’s life. The arithmetic is simple: if you draw 2 to 3 mL from a 10 mL vial in 28 days, the other 7 to 8 mL (70% to 80% of the vial) is discarded on day 28.
That is the case the PureBac 3 mL bacteriostatic water vial is sized for:
- Choose 10 mL: If you draw several milliliters a week, or run more than one reconstitution in the same 28 days (or select our Duo Bundle).
- Choose 3 mL: If you reconstitute a single lyophilized vial that takes 2 to 3 mL of diluent. You open only what you will use, and each new vial starts its own 28-day window.
The cost side of that choice, with price per mL actually used, is worked out in 10 mL vs 3 mL bacteriostatic water and in our guide to 5 mL and other small vials.
Ready to organize your reconstitution protocol?
Explore our laboratory solutions or calculate exact syringe dosages with our free tool:
Frequently Asked Questions
Can I use bacteriostatic water past 28 days if it still looks clear?
No. Contamination at levels that can cause infection is often invisible, so a clear vial is not proof that it is sterile. USP <797> and CDC count the 28 days from the first puncture regardless of how the liquid looks. The only exception is a different date stated by the manufacturer for that opened vial.
Can I freeze bacteriostatic water to extend its shelf life?
No. The FDA-approved label gives one storage range, 20 to 25°C (68 to 77°F), and no freezing instruction, so a frozen vial is outside the conditions its expiration date was based on. Water also expands as it freezes, which can stress the stopper seal and the container. Freezing extends neither the expiration date nor the 28-day limit.
What is the shelf life of an unopened bacteriostatic water vial?
Until the expiration date printed on the vial and carton, provided it was stored at 20 to 25°C (68 to 77°F) as the label directs. Each manufacturer sets that date from its own stability testing, so read the printed date rather than assuming a fixed number of months.
Does refrigerating an opened vial of bacteriostatic water make it last longer than 28 days?
No. The 28-day limit in USP <797> and CDC guidance counts from first entry and is not tied to storage temperature. The Hospira label stores bacteriostatic water at 20 to 25°C and does not call for refrigeration. Refrigeration matters only after the water is mixed with a drug, and then the drug's label sets the rules.
Why is the limit 28 days and not longer?
USP <797> assigns 28 days to an opened multiple-dose container unless antimicrobial effectiveness testing for that product supports a different period, and CDC uses the same figure. It is a fixed administrative limit, not a measured point at which every vial fails. It caps how long one contaminated entry can go on being drawn into later doses.
References & Primary Sources
Every technical claim on this page is sourced to a pharmacopeial monograph, a federal regulatory body, or peer-reviewed literature. Links open the primary source directly.
- Regulatory / pharmacopeialGeneral Chapter ⟨797⟩ Pharmaceutical Compounding: Sterile Preparations
- Public health authorityPreventing Unsafe Injection Practices
- Regulatory / pharmacopeialBacteriostatic Water for Injection, USP: FDA prescribing information (Hospira, Inc.)
- Public health authorityMulti-Dose Vial Safety Reminders
- Regulatory / pharmacopeialGeneral Chapter ⟨51⟩ Antimicrobial Effectiveness Testing
- Peer-reviewed literatureAntibacterial activity of phenolic compounds and aromatic alcohols
- Regulatory / pharmacopeialBacteriostatic Water for Injection (official monograph)
- Public health authorityCDC Grand Rounds: Preventing Unsafe Injection Practices in the U.S. Health-Care System
- Public health authorityOutbreaks and Patient Notifications in Outpatient Settings, Selected Examples, 2010-2014
- Regulatory / pharmacopeialGeneral Chapter ⟨660⟩ Containers: Glass
